A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder

Robert R. Selles, Joseph McGuire, Brent J. Small, Eric A. Storch

Research output: Contribution to journalArticle

Abstract

Objective While individual trials suggest benefit of interventions for excoriation (skin-picking) disorder (ExD), limited systematic evaluation of treatments, or their collective benefit, exists. Methods The present study examined the current state of treatments for ExD in a systematic review and meta-analysis and explored potential treatment moderators. Twelve trials were identified for review, including five with a control condition. Of these, nine were eligible to be included in the meta-analysis (three with a control). Results A fixed-effects meta-analysis found a large overall treatment effect size (g = 1.13), comprised of large effects for behavioral treatments (g = 1.19), lamotrigine (g = 0.98) and selective serotonin reuptake inhibitors (g = 1.09). Clinician-rated measures did not significantly differ from self-rated measures; however, larger effects were observed on self-rated measures of severity, as compared to impairment [Q(1) = 4.63, P = .03]. Treatment type, trial length and trial methodological quality were not significant moderators. For controlled trials, the comparative efficacy of treatments for ExD was in the moderate range (g = 0.47). Conclusion Findings suggest that treatment for ExD has benefit; however, the meta-analysis did not provide strong evidence to support any specific treatment or to suggest its unique clinical benefit over control conditions. Overall, there is a lack of study on treatments for ExD and additional randomized controlled trials with inclusion of multiple informants in assessment is needed.

Original languageEnglish (US)
Pages (from-to)29-37
Number of pages9
JournalGeneral Hospital Psychiatry
Volume41
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Psychiatry
Meta-Analysis
Skin
Serotonin Uptake Inhibitors
Randomized Controlled Trials

Keywords

  • Behavioral treatment
  • Excoriation disorder
  • Pharmacological treatment
  • Therapy

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder. / Selles, Robert R.; McGuire, Joseph; Small, Brent J.; Storch, Eric A.

In: General Hospital Psychiatry, Vol. 41, 01.07.2016, p. 29-37.

Research output: Contribution to journalArticle

@article{5371832cb8ae4ba5bd01e4286390a7b8,
title = "A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder",
abstract = "Objective While individual trials suggest benefit of interventions for excoriation (skin-picking) disorder (ExD), limited systematic evaluation of treatments, or their collective benefit, exists. Methods The present study examined the current state of treatments for ExD in a systematic review and meta-analysis and explored potential treatment moderators. Twelve trials were identified for review, including five with a control condition. Of these, nine were eligible to be included in the meta-analysis (three with a control). Results A fixed-effects meta-analysis found a large overall treatment effect size (g = 1.13), comprised of large effects for behavioral treatments (g = 1.19), lamotrigine (g = 0.98) and selective serotonin reuptake inhibitors (g = 1.09). Clinician-rated measures did not significantly differ from self-rated measures; however, larger effects were observed on self-rated measures of severity, as compared to impairment [Q(1) = 4.63, P = .03]. Treatment type, trial length and trial methodological quality were not significant moderators. For controlled trials, the comparative efficacy of treatments for ExD was in the moderate range (g = 0.47). Conclusion Findings suggest that treatment for ExD has benefit; however, the meta-analysis did not provide strong evidence to support any specific treatment or to suggest its unique clinical benefit over control conditions. Overall, there is a lack of study on treatments for ExD and additional randomized controlled trials with inclusion of multiple informants in assessment is needed.",
keywords = "Behavioral treatment, Excoriation disorder, Pharmacological treatment, Therapy",
author = "Selles, {Robert R.} and Joseph McGuire and Small, {Brent J.} and Storch, {Eric A.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.genhosppsych.2016.04.001",
language = "English (US)",
volume = "41",
pages = "29--37",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder

AU - Selles, Robert R.

AU - McGuire, Joseph

AU - Small, Brent J.

AU - Storch, Eric A.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Objective While individual trials suggest benefit of interventions for excoriation (skin-picking) disorder (ExD), limited systematic evaluation of treatments, or their collective benefit, exists. Methods The present study examined the current state of treatments for ExD in a systematic review and meta-analysis and explored potential treatment moderators. Twelve trials were identified for review, including five with a control condition. Of these, nine were eligible to be included in the meta-analysis (three with a control). Results A fixed-effects meta-analysis found a large overall treatment effect size (g = 1.13), comprised of large effects for behavioral treatments (g = 1.19), lamotrigine (g = 0.98) and selective serotonin reuptake inhibitors (g = 1.09). Clinician-rated measures did not significantly differ from self-rated measures; however, larger effects were observed on self-rated measures of severity, as compared to impairment [Q(1) = 4.63, P = .03]. Treatment type, trial length and trial methodological quality were not significant moderators. For controlled trials, the comparative efficacy of treatments for ExD was in the moderate range (g = 0.47). Conclusion Findings suggest that treatment for ExD has benefit; however, the meta-analysis did not provide strong evidence to support any specific treatment or to suggest its unique clinical benefit over control conditions. Overall, there is a lack of study on treatments for ExD and additional randomized controlled trials with inclusion of multiple informants in assessment is needed.

AB - Objective While individual trials suggest benefit of interventions for excoriation (skin-picking) disorder (ExD), limited systematic evaluation of treatments, or their collective benefit, exists. Methods The present study examined the current state of treatments for ExD in a systematic review and meta-analysis and explored potential treatment moderators. Twelve trials were identified for review, including five with a control condition. Of these, nine were eligible to be included in the meta-analysis (three with a control). Results A fixed-effects meta-analysis found a large overall treatment effect size (g = 1.13), comprised of large effects for behavioral treatments (g = 1.19), lamotrigine (g = 0.98) and selective serotonin reuptake inhibitors (g = 1.09). Clinician-rated measures did not significantly differ from self-rated measures; however, larger effects were observed on self-rated measures of severity, as compared to impairment [Q(1) = 4.63, P = .03]. Treatment type, trial length and trial methodological quality were not significant moderators. For controlled trials, the comparative efficacy of treatments for ExD was in the moderate range (g = 0.47). Conclusion Findings suggest that treatment for ExD has benefit; however, the meta-analysis did not provide strong evidence to support any specific treatment or to suggest its unique clinical benefit over control conditions. Overall, there is a lack of study on treatments for ExD and additional randomized controlled trials with inclusion of multiple informants in assessment is needed.

KW - Behavioral treatment

KW - Excoriation disorder

KW - Pharmacological treatment

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=84975744785&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975744785&partnerID=8YFLogxK

U2 - 10.1016/j.genhosppsych.2016.04.001

DO - 10.1016/j.genhosppsych.2016.04.001

M3 - Article

C2 - 27143352

AN - SCOPUS:84975744785

VL - 41

SP - 29

EP - 37

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

ER -